Biological tumor volume in 18 FET-PET before radiochemotherapy correlates with survival in GBM
Year: 2015
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: The aim of this prospective longitudinal study was to identify static and dynamic O-(2-[(18)F]fluoroethyl)-L-tyrosine PET ((18)FET-PET)-derived imaging biomarkers in patients with glioblastoma (GBM). METHODS: Seventy-nine patients with newly diagnosed GBM were included; 42 patients underwent stereotactic biopsy (unresectable tumors) and 37 patients microsurgical tumor resection. All patients were scheduled to receive radiotherapy plus concomitant and adjuvant temozolomide (RCx/TMZ). (18)FET-PET evaluation using static and dynamic analysis was done before biopsy/resection, after resection, 4 to 6 weeks following RCx, and after 3 cycles of TMZ. Endpoints were survival and progression-free-survival. Prognostic factors were obtained from proportional hazards models. RESULTS: Biological tumor volume before RCx (BTV(preRCx)) was the most important (18)FET-PET-derived imaging biomarker and was independent of MGMT promoter methylation and clinical prognostic factors: patients with smaller BTV(preRCx) had significantly longer progression-free and overall survival (OS). (18)FET time-activity curves (TACs) before treatment and their changes after RCx were also related to outcome; patients with initially increasing TACs experienced longer OS. CONCLUSION: BTV(preRCx) and TAC represent important (18)FET-PET-derived imaging biomarkers in GBM. Increasing TACs are associated with prolonged OS. The BTV(preRCx) is a strong prognostic factor for progression-free survival and OS independent of the mode of surgery. Our data furthermore suggest that patients harboring resectable GBM might benefit from maximal PET-guided tumor resection.
Source: Neurology
Authors: Bogdana Suchorska, Nathalie L. Jansen, Jennifer Linn, Hans Kretzschmar, Hendrik Janssen, Sabina Eigenbrod, Matthias Simon, Gabriele Pöpperl, Friedrich W. Kreth, Christian la Fougere, Michael Weller, Joerg C. Tonn, For the German Glioma Network, Bogdana Suchorska, Nathalie Lisa Jansen, Jennifer Linn, Hans Kretzschmar, Hendrik Janssen, Sabina Eigenbrod, Matthias Simon, Gabriele Pöpperl, Friedrich Wilhelm Kreth, Christian La Fougere, Michael Weller, Joerg Christian Tonn, Oliver Schnell, Julia Geisler, Bettina Henschel
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Acceleron, Deutsche Krebshilfe
Award: G3253687583
OpenAlex ID: W2109896919
